Results 191 to 200 of about 14,242 (206)
Some of the next articles are maybe not open access.
Effect of baseline carbohydrate antigen 19-9 (CA19-9) level on overall survival (OS) in NAPOLI-1: A randomized phase III study of MM-398 (nal-IRI), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine (gem)-based therapy.
Journal of Clinical Oncology, 2016 Li-Tzong Chen, Jens T Siveke, Andrea Wang-Gillam, Richard Hubner, Shubham Pant, Tomislav Dragovich, Vincent M. Chung, David Z. Chang, Paul J. Ross, Prasad Cooray, Niall C. Tebbutt, Fabio A. Franke, Bruce Belanger, Navreet Dhindsa, Floris de Jong, Khalid Mamlouk, Daniel D. Von Hoff +16 moreopenaire +1 more source[Histochemical visualization of carbohydrate antigen 19-9 (CA19-9) in pancreas from patients with pancreatic cancer by using a monoclonal antibody].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1985 H, Miyaoka, M, Onchi, Z, Yamashita, Y, Danjo, T, Horiike +4 moreopenaire +1 more source[Usefulness of carbohydrate antigen 19-9 (CA19-9) for the diagnosis of cholangioma. As a role of screening patients with the elevation of serum alkaline phosphatase, leucine aminopeptidase and/or gamma-glutamyl transpeptidase].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1985 O, Yamanaka, T, Kawanami, H, Ozaki, S, Tominaga, T, Iijima +4 moreopenaire +1 more source